← Open Payments lookup

GRIGOR GRIGORYAN: Open Payments

NPI 1205382231 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$559 in 24 payments from 11 companies in 2025. Trend: 2023 $1,165 · 2024 $1,268 · 2025 $559

Food & beverage: $559
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.4$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$136
Stemline Therapeutics Inc.2$65
E.R. Squibb & Sons, L.L.C.2$37
Merck Sharp & Dohme LLC1$32
RECORDATI_RARE_DISEASES_INC.1$28
Otsuka America Pharmaceutical, Inc.1$28
pharmaand GmbH1$28
Neuronetics, Inc.3$24
Supernus Pharmaceuticals, Inc.1$20

Products named: HETLIOZ, CAPLYTA, Orserdu, COBENFY, WELIREG, SYLVANT, ABILIFY ASIMTUFII, Rubraca.

Industry payments across CA — which companies pay providers there.